KaloBios Pharmaceuticals, Inc. Appoints Donald R. Joseph as Chief Legal Officer
6/18/2013 9:18:36 AM
More...
|
KaloBios Pharmaceuticals, Inc. Reports First Quarter 2013 Financial Results
5/15/2013 6:56:04 AM
More...
|
KaloBios Pharmaceuticals, Inc. to Present at Credit Suisse Antibody Conference
5/9/2013 6:28:13 AM
More...
|
KaloBios Pharmaceuticals, Inc. to Present at Needham Healthcare Conference
4/25/2013 6:32:36 AM
More...
|
KaloBios Pharmaceuticals, Inc.' Targeted Antibacterial KB001-A to be Featured in Biotechnology Industry Organization (BIO) 2013 Panel Discussion of "New Defenses Against Old Enemies"
4/18/2013 6:35:02 AM
More...
|
KaloBios Pharmaceuticals, Inc. to Present at Future Leaders in the Biotech Industry Conference
4/2/2013 6:22:39 AM
More...
|
KaloBios Pharmaceuticals, Inc. Announces Fiscal Year 2012 Financial Results
3/28/2013 6:43:02 AM
More...
|
KaloBios Pharmaceuticals, Inc. Presents Clinical Results With Anti-GM-CSF Antibody in Persistent Asthma Data From KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting
2/27/2013 9:26:32 AM
More...
|
KaloBios Pharmaceuticals, Inc. Completes Initial Public Offering
2/7/2013 9:47:52 AM
More...
|
KaloBios Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
2/1/2013 9:01:15 AM
More...
|
|